U.S. Physical Therapy price target raised to $120 from $111 at Barrington

Barrington raised the firm’s price target on U.S. Physical Therapy to $120 from $111 and keeps an Outperform rating on the shares. The company’s efforts to improve commercial contracts are ongoing and should result in favorable pricing in its commercial business for at least the next three years in the range of 1.5%-2.5% annually, the analyst tells investors in a research note. The stock is on the firm’s best ideas list for 2024.